Showing results (331-340 of 350) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Investigation|September 7, 2006
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsJohannes-Peter Stasch, Peter M Schmidt, Pavel I Nedvetsky, et al.
Nature Communications|October 8, 2015
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in miceRobrecht Thoonen, Anje Cauwels, Kelly Decaluwe, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
JCI Insight|February 23, 2018
Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fractionNicola Wilck, Lajos Markó, András Balogh, et al.
Circulation. Cardiovascular Genetics|November 6, 2014
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlandersMartin R Wilkins, Almaz A Aldashev, John Wharton, et al.
Heart Failure Reviews|May 25, 2012
Soluble guanylate cyclase: a potential therapeutic target for heart failureMihai Gheorghiade, Catherine N Marti, Hani N Sabbah, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 8, 2020
Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo StudiesW A Ferreira, H Chweih, C Lanaro, et al.
American Journal of Respiratory Cell and Molecular Biology|December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell DiseaseKarin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Nature|February 15, 2019
Singlet molecular oxygen regulates vascular tone and blood pressure in inflammationChristopher P Stanley, Ghassan J Maghzal, Anita Ayer, et al.
Journal of Medicinal Chemistry|May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart FailureMarkus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
Pageof 35